v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]    
Schedule of the Black-Scholes Option-Pricing Model
The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
 
    
Six Months Ended June 30,
    
2026
  
2025
Dividend yield
   0.00%    0.00%
Expected volatility
   28.8%    36.2%
Risk-free interest rate
   4.1%    4.1%
Expected term (years)
   5.9    5.7
The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
 
    
  Year Ended December 31,  
    
   2025   
 
   2024   
Dividend yield
   0.00%   0.00%
Expected volatility
   34.9%   39.7%
Risk-free interest rate
   4.1%   4.2%
Expected term (years)
   5.7   6.9
Schedule of Stock Option
A summary of stock option activity is as follows:
 
 
  
Common stock
options
 
 
Weighted-average

exercise price
 
  
Weighted-average

remaining
contractual term
(years)
 
  
Aggregate Intrinsic
Value
 
Outstanding - December 31, 2025
        1,137,387      $ 1.05        9.4     
Granted
     791,500    $ 4.58        
Exercised
     (10,000 )    $ 1.31        
Forfeited or expired
     -      $ -        
  
 
 
 
        
Outstanding - June 30, 2026
        1,918,887      $ 2.51        9.3      $ 11,481,126  
  
 
 
 
        
Exercisable - June 30, 2026
     728,731      $      1.58        7.8      $ 5,032,162  
  
 
 
 
        
A summary of stock option activity is as follows:
 
    
Common stock
options
    
Weighted-average

exercise price
    
Weighted-average

remaining
contractual term
(years)
  
Aggregate Intrinsic
Value
 
Outstanding - December 31, 2023
     635,000       $ 0.46      9.4   
 Granted
     542,500       $ 1.31        
 Exercised
     (10,000)       $ 0.00        
 Forfeited / expired
     (90,000)       $ 1.02        
  
 
 
          
Outstanding - December 31, 2024
     1,077,500       $ 0.85      10.0   
 Granted
     263,000       $ 1.32        
 Exercised
     (7,800)       $ 1.31        
 Forfeited
     (195,313)       $ 0.28        
  
 
 
          
Outstanding - December 31, 2025
     1,137,387        $ 1.05      9.4    $ 304,006  
  
 
 
          
Exercisable - December 31, 2025
     520,847        $ 0.84      7.94    $ 251,094  
  
 
 
          
Schedule of Restricted Stock Award
A summary of restricted stock award activity for the six months ended June 30, 2026, is as follows:
 
    
Number of Shares
 
Weighted-Average

Grant-Date Fair
Value
 
Nonvested - December 31, 2025
     171,875     $ 0.0001  
Vested
     (93,750)     $ 0.0001  
  
 
 
 
 
Nonvested - June 30, 2026
     78,125     $      0.0001  
  
 
 
 
 
A summary of restricted stock award activity for the year ended December 31, 2025 is as follows:
 
    
Number of Shares
   
Weighted-Average

Grant-Date Fair
Value
 
Nonvested - January 1, 2025
     359,375      $ 0.0001  
Vested
     (187,500)     $ 0.0001  
  
 
 
   
Nonvested - December 31, 2025
     171,875      $ 0.0001  
  
 
 
   
Schedule of Stock Based Compensation Expense
Stock based compensation expense is included in the unaudited condensed consolidated statements of operations and comprehensive loss as follows:

    
Three Months Ended June 30,
    
Six Months Ended June 30,
 
    
2026
    
2025
    
2026
    
2025
 
Research and development
    $ 23,855        $ 23,679        $ 47,481        $ 38,114   
General and administrative
     227,419         10,891         243,434         17,420   
  
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
    $     251,274        $     34,570        $     290,915        $     55,534   
  
 
 
    
 
 
    
 
 
    
 
 
 
Stock based compensation expense is included in the consolidated statements of
operations
and comprehensive
loss
as follows:
    
Years Ended December 31,
 
    
   2025   
   
   2024   
 
Research and
development
     81,015     $ 68,281  
General and administrative
     43,832       27,732  
  
 
 
   
 
 
 
Total stock-based compensation
   $ 124,847     $ 96,013